Evidence map›Paper›PMID 30383396›Full record

ArticleAmerican journal of respiratory cell and molecular biology2019

Autophagy Activation in Asthma Airways Remodeling.

Kielan D McAlinden, Deepak A Deshpande, Saeid Ghavami, Dia Xenaki, Sukhwinder Singh Sohal, Brian G Oliver, Mehra Haghi, Pawan Sharma

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 2 syntheses or guidelines pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Autophagy in chronic rhinosinusitis with or without nasal polyps.Frontiers in cell and developmental biology · 2024
    Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Kielan D McAlinden1 Graduate School of Health and.
Deepak A Deshpande4 Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Saeid Ghavami5 Department of Anatomy & Cell Science, University of Manitoba, Winnipeg, Manitoba, Canada; and.
Dia Xenaki2 Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Sukhwinder Singh Sohal6 Respiratory Translational Research Group, Department of Laboratory Medicine, University of Tasmania, Launceston, Tasmania, Australia.
Brian G Oliver3 School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.
Mehra Haghi1 Graduate School of Health and.
Pawan Sharma3 School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-2904-2306
University of Technology Sydney · AUGraduate School USA · USThe University of Sydney · AUThomas Jefferson University · USUniversity of Manitoba · CAUniversity of Tasmania · AU

Funding

Functional Diversity of Compartmentalized Calcium Signaling in Airway Smooth MuscleR01HL137030 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI DESHPANDE, DEEPAK A · 2018 to 2021
$2.2M
NHLBI NIH HHS R01 HL137030
6 · The paper itself

Abstract

Current asthma therapies fail to target airway remodeling that correlates with asthma severity driving disease progression that ultimately leads to loss of lung function. Macroautophagy (hereinafter "autophagy") is a fundamental cell-recycling mechanism in all eukaryotic cells; emerging evidence suggests that it is dysregulated in asthma. We investigated the interrelationship between autophagy and airway remodeling and assessed preclinical efficacy of a known autophagy inhibitor in murine models of asthma. Human asthmatic and nonasthmatic lung tissues were histologically evaluated and were immunostained for key autophagy markers. The percentage area of positive staining was quantified in the epithelium and airway smooth muscle bundles using ImageJ software. Furthermore, the autophagy inhibitor chloroquine was tested intranasally in prophylactic (3 wk) and treatment (5 wk) models of allergic asthma in mice. Human asthmatic tissues showed greater tissue inflammation and demonstrated hallmark features of airway remodeling, displaying thickened epithelium (

Indexed as

AdolescentAdultAgedAged, 80 and overAirway RemodelingAnimalsAnti-Asthmatic AgentsAsthmaAutophagyAutophagy-Related Protein 5Beclin-1Case-Control StudiesChloroquineCiliaDisease Models, AnimalFemaleAnti-Asthmatic AgentsATG5 protein, humanAutophagy-Related Protein 5Beclin-1BECN1 protein, humanChloroquineSequestosome-1 ProteinSQSTM1 protein, humanasthmaautophagyBeclin-1immunohistochemistryremodeling

Identifiers

PMID30383396
PMCPMC6503620
OpenAlexW2898864613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.